+1 877 705 1914• 24 / 7
HIPAA Compliant
ISO 27001 Certified

Actively Recruiting

All Ages
All Genders
Healthy Volunteers
ID01193088

Genetic Study of Charcot-Marie-Tooth Disease Including CMT1A Modifiers and New Causes of CMT

Led by University of Iowa · Updated on 2026-10-27

1050

Participants Needed

24

Research Sites

N/A

Total Duration

AI-Summary

What This Trial Is About

Researchers are studying Charcot-Marie-Tooth disease CMT, focusing on finding new genes that cause the disease and identifying genes that may modify symptoms in people with CMT. This project includes participants who have either CMT type 1A or an unknown form of CMT. The goal is to better understand how genetic factors influence the severity of the disease and to discover new genetic causes that have not yet been identified. Participants will provide blood samples, which will be sent to the University of Miami for exome sequencing to analyze their genetic information. This genetic testing is optional for participants. The study groups include families or individuals with genetically defined CMT1A and those with genetically undefined CMT where common causes have been ruled out. During the study, participants will be assessed through their genetic data, with researchers focusing on gene modifiers of CMT1A and new genetic causes of CMT. There are no interventions or treatments given, as this is an observational study. The study is expected to continue until December 2030, and participants may be contacted for follow-up as needed based on the research progress.

CONDITIONS

Brief Title

Genetics of Charcot Marie Tooth (CMT) - Modifiers of CMT1A, New Causes of CMT2

Research Team

T

Tiffany Grider, MS, CGC

N

Nicole Kressin, MSN, RN

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here